TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $193,050 | +20.7% | 12,375 | +0.4% | 0.00% | – |
Q3 2022 | $160,000 | -10.6% | 12,320 | -3.5% | 0.00% | – |
Q2 2022 | $179,000 | -2.2% | 12,768 | 0.0% | 0.00% | – |
Q1 2022 | $183,000 | -61.9% | 12,768 | -63.8% | 0.00% | – |
Q4 2021 | $480,000 | -50.5% | 35,229 | -40.5% | 0.00% | -100.0% |
Q3 2021 | $970,000 | -33.6% | 59,231 | -31.8% | 0.00% | 0.0% |
Q2 2021 | $1,461,000 | +266.2% | 86,797 | +297.3% | 0.00% | – |
Q1 2021 | $399,000 | -45.7% | 21,846 | -45.9% | 0.00% | – |
Q4 2020 | $735,000 | -76.7% | 40,367 | -77.2% | 0.00% | -100.0% |
Q3 2020 | $3,152,000 | -64.8% | 176,690 | -64.6% | 0.00% | -66.7% |
Q2 2020 | $8,943,000 | +679.0% | 498,764 | +559.8% | 0.01% | +500.0% |
Q1 2020 | $1,148,000 | -67.1% | 75,598 | -57.2% | 0.00% | -66.7% |
Q4 2019 | $3,489,000 | +53.6% | 176,821 | +33.9% | 0.00% | +50.0% |
Q3 2019 | $2,271,000 | -72.9% | 132,073 | -72.1% | 0.00% | -71.4% |
Q2 2019 | $8,385,000 | +105.9% | 473,763 | +137.0% | 0.01% | +75.0% |
Q1 2019 | $4,072,000 | -82.3% | 199,908 | -85.4% | 0.00% | -83.3% |
Q4 2018 | $23,008,000 | – | 1,367,880 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |